Genomics

Dataset Information

KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas


ABSTRACT: KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas

PROVIDER: PRJNA643585 | ENA |

REPOSITORIES: ENA